Pasting traditional Chinese medicine ointment for treating urinary incontinence
By developing a Chinese ointment containing specific Chinese medicine ingredients, and through umbilical therapy combined with infrared heating, the problem of urinary incontinence treatment in the prior art is solved, and a non-invasive, safe and effective urinary incontinence treatment effect has been achieved.
Patent Information
- Application Number
- CN202411912330.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-24
- Publication Date
- 2025-02-25
AI Technical Summary
The prior art mainly relies on Western medicine and surgery when treating urinary incontinence. Although it works quickly, it causes great harm to the body and lacks non-invasive, safe and effective treatment methods.
Develop a Chinese ointment that includes aconite, poria, cinnamon, frankincense, myrrh, Sichuan Achyranthes, Blood Death, Hakodatus, Haier, Zelan and honey. It is treated through umbilical therapy, and combined with infrared heating to achieve the effect of warming yang, strengthening astringent, nourishing the kidney and nourishing qi.
This method is non-invasive and safe, significantly improves urinary incontinence symptoms, reduces the number and amount of urinary incontinence, improves urine control ability, and improves the quality of life of patients.
Smart Images

Figure CN119499318A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of applying Chinese medicinal ointment, and more specifically, to an applying Chinese medicinal ointment for treating urinary incontinence. Background Art
[0002] In terms of clinical application, umbilical therapy is widely used in digestive system diseases, respiratory system diseases, gynecological diseases, urinary system diseases, etc. For example, umbilical stickers can relieve symptoms such as stomach pain and fullness caused by chronic gastritis and gastric ulcers; umbilical therapy can improve respiratory function of chronic bronchitis, asthma, etc., and relieve symptoms such as cough and wheezing; in the field of gynecology, umbilical therapy has a good effect on diseases such as irregular menstruation, dysmenorrhea, and pelvic inflammatory disease.
[0003] However, in the process of treating urinary incontinence, Western medicine and surgical treatment are generally used. Although this type of method is effective quickly, it is more harmful to the body and will cause additional impact on the patient. Therefore, it is particularly important to treat the patient's symptoms while reducing the impact of the drug on the patient.
[0004] Therefore we propose a Chinese medicine ointment for treating urinary incontinence to solve the above problems. Summary of the invention
[0005] In order to overcome the above-mentioned defects of the prior art, an embodiment of the present invention provides a Chinese medicine ointment for treating urinary incontinence to solve the problems raised in the above-mentioned background technology.
[0006] To achieve the above object, the present invention provides the following technical solution: a Chinese medicine ointment for treating urinary incontinence, comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials;
[0007] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0008] Step S1, weighing an appropriate amount of pharmaceutical raw materials;
[0009] Step S2, grinding the medicinal materials into powder and mixing them;
[0010] Step S3, making all the mixed drug powders into drug micropowders;
[0011] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0012] Step S5, add honey to the medicine juice and mix evenly to prepare a Chinese medicine ointment, and prepare the ointment required for each treatment separately into pills and seal them for storage. Each time the pills are used, they are taken out and placed in the umbilical fossa for external application, and infrared heating can be used at the same time to achieve the effects of warming yang, consolidating astringency, tonifying the kidney and replenishing qi, and achieving the therapeutic effect on urinary incontinence.
[0013] In a preferred embodiment, the auxiliary material is honey.
[0014] In a preferred embodiment, the pharmaceutical raw materials include the following components: 2 parts of aconite, 1.5 parts of Poria, 1 part of cinnamon, 0.7 parts of frankincense, 0.7 parts of myrrh, 1.3 parts of Cyathula, 1.3 parts of Sanguisorba officinalis, 1.3 parts of Terminalia chebula, 1 part of cuttlebone, and 1 part of Zedoaria.
[0015] In a preferred embodiment, in step S1, an appropriate amount of pharmaceutical raw materials is dried.
[0016] In a preferred embodiment, in step S2, the raw material dried in step S1 is ground into powder.
[0017] In a preferred embodiment, in step S2, the ground medicinal raw materials are fully sieved to obtain drug powders and then mixed.
[0018] In a preferred embodiment, in step S2, the screening size is 75 mm to 150 mm.
[0019] In a preferred embodiment, in step S3, the drug powder mixed in step S2 is made into drug micro powder by micronization technology.
[0020] Technical effects and advantages of the present invention:
[0021] This method gets rid of the traditional treatment methods of urinary incontinence such as oral medication and surgery, and can achieve the purpose of improving clinical treatment effects in a non-invasive, safe and effective manner, and significantly improve the quality of life of patients. After umbilical therapy, the symptoms of patients with urinary incontinence have been significantly improved. After using the umbilical therapy method, the frequency and amount of urinary incontinence of patients have been significantly reduced, and the ability to control urine has been significantly improved. The patented formula takes tonifying the kidney and consolidating the astringent, replenishing qi and consolidating the foundation, and harmonizing the lung, spleen and kidney functions as the main treatment principles, which can regulate the functions of human organs, regulate nerve sensitivity, and enhance the control ability of bladder muscles, thereby improving the symptoms of urinary incontinence. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 It is a schematic diagram of the production process of Chinese medicinal ointment of the present invention. DETAILED DESCRIPTION
[0023] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0024] Allergic reactions
[0025] Due to individual differences, some patients may have allergic reactions to certain ingredients in navel administration. Allergic reactions may manifest as symptoms such as skin redness, itching, and rash. In severe cases, they may even experience life-threatening allergic reactions such as difficulty breathing, increased heart rate, and decreased blood pressure. Therefore, before using navel administration, patients should understand the drug ingredients in detail and conduct necessary allergy tests.
[0026] Skin damage
[0027] The skin around the navel is relatively delicate, and prolonged or improper use of navel medication may cause skin damage. Skin damage may manifest as symptoms such as skin redness, ulceration, and infection, which may affect the patient's daily life in severe cases. Therefore, when using navel medication, patients should follow the doctor's instructions, pay attention to the method and time of medication, and avoid unnecessary damage to the skin.
[0028] Malabsorption of drugs
[0029] The efficacy of navel administration depends on the skin absorption of the drug. However, due to individual differences and differences in drug ingredients, some patients may experience poor drug absorption. Poor drug absorption may lead to poor treatment effects or even delay the disease. Therefore, when using navel administration, patients should pay close attention to the treatment effect and seek medical attention in time if they feel uncomfortable.
[0030] Drug interactions
[0031] Navel administration may interact with other drugs that the patient is currently taking, affecting the efficacy of the drug or increasing the risk of adverse reactions. Therefore, before using the navel administration, the patient should tell the doctor in detail about his or her medication history so that the doctor can assess the risk of drug interactions.
[0032] The treatment population is relatively limited
[0033] Currently, the more common umbilical compress medicines are mostly for children, the elderly or postpartum women. There is a lack of effective products that can be used by most patient groups, which limits the clinical application of umbilical medication to treat urinary incontinence. Therefore, there is an urgent need for a product with a wide range of applications, definite efficacy, simplicity and safety.
[0034] The composition of the navel prescription for navel administration is gradually formulated based on the summary and adjustment of many years of clinical experience. From the perspective of traditional Chinese medicine, the occurrence of urinary incontinence may be related to dysfunction of the kidney, spleen, lung and other internal organs. The kidney governs water and controls defecation and urination. If the kidney qi is not solid, the bladder will lose control and urinary incontinence will easily occur. The spleen governs transportation and transformation. If the spleen is weak, the middle qi will sink, which may also lead to the inability to control the lower organs. The lung governs qi and controls breathing, and regulates the water channels. Insufficient lung qi will also affect water metabolism and the normal function of the bladder. This patented prescription takes tonifying the kidney and consolidating, replenishing qi and consolidating the foundation, and harmonizing the functions of the lungs, spleen and kidneys as the main principles of treatment. It can regulate the functions of human internal organs, regulate nerve sensitivity, and enhance the control ability of bladder muscles, thereby improving the symptoms of urinary incontinence.
[0035] Embodiment 1:
[0036] Reference Figure 1 , a Chinese medicine ointment for treating urinary incontinence, characterized by comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials; the auxiliary material is honey;
[0037] The pharmaceutical raw materials include the following components: 2 parts of aconite root, 0.5 parts of Poria cocos, 1 part of cinnamon bark, 0.7 parts of frankincense, 0.7 parts of myrrh, 1.3 parts of Cyathula officinalis, 1.3 parts of Sanguisorba officinalis, 1.3 parts of Terminalia chebula, 1 part of Cuttlebone, and 1 part of Zedoariae;
[0038] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0039] Step S1, weighing an appropriate amount of pharmaceutical raw materials; In step S1, drying an appropriate amount of pharmaceutical raw materials;
[0040] Step S2, grinding the medicinal raw materials into powder and mixing them; in step S2, grinding the raw materials dried in step S1 into powder; in step S2, fully sieving the ground medicinal raw materials to obtain drug powder and mixing them; in step S2, the sieving size is: 75 mm to 150 mm;
[0041] Step S3, all the mixed drug powders are made into drug micro powders; In step S3, all the mixed drug powders in step S2 are made into drug micro powders by micronization technology;
[0042] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0043] Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
[0044] Embodiment 2:
[0045] Reference Figure 1, a Chinese medicine ointment for treating urinary incontinence, characterized by comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials; the auxiliary material is honey;
[0046] The pharmaceutical raw materials include the following components: 2 parts of aconite root, 1 part of tuckahoe, 1 part of cinnamon bark, 0.7 parts of frankincense, 0.7 parts of myrrh, 1.3 parts of cyathula, 1.3 parts of dragon's blood, 1.3 parts of terminalia chebula, 1 part of cuttlebone, and 1 part of zedoaria;
[0047] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0048] Step S1, weighing an appropriate amount of pharmaceutical raw materials; In step S1, drying an appropriate amount of pharmaceutical raw materials;
[0049] Step S2, grinding the medicinal raw materials into powder and mixing them; in step S2, grinding the raw materials dried in step S1 into powder; in step S2, fully sieving the ground medicinal raw materials to obtain drug powder and mixing them; in step S2, the sieving size is: 75 mm to 150 mm;
[0050] Step S3, all the mixed drug powders are made into drug micro powders; In step S3, all the mixed drug powders in step S2 are made into drug micro powders by micronization technology;
[0051] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0052] Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
[0053] Embodiment three:
[0054] Reference Figure 1 , a Chinese medicine ointment for treating urinary incontinence, characterized by comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials; the auxiliary material is honey;
[0055] The pharmaceutical raw materials include the following components: 2 parts of aconite root, 1.5 parts of tuckahoe, 1 part of cinnamon bark, 0.7 parts of frankincense, 0.7 parts of myrrh, 1.3 parts of cyathula, 1.3 parts of dragon's blood, 1.3 parts of terminalia chebula, 1 part of sea cucumber, and 1 part of zedoaria;
[0056] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0057] Step S1, weighing an appropriate amount of pharmaceutical raw materials; In step S1, drying an appropriate amount of pharmaceutical raw materials;
[0058] Step S2, grinding the medicinal raw materials into powder and mixing them; in step S2, grinding the raw materials dried in step S1 into powder; in step S2, fully sieving the ground medicinal raw materials to obtain drug powder and mixing them; in step S2, the sieving size is: 75 mm to 150 mm;
[0059] Step S3, all the mixed drug powders are made into drug micro powders; In step S3, all the mixed drug powders in step S2 are made into drug micro powders by micronization technology;
[0060] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0061] Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
[0062] Embodiment 4:
[0063] Reference Figure 1 , a Chinese medicine ointment for treating urinary incontinence, characterized by comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials; the auxiliary material is honey;
[0064] The pharmaceutical raw materials include the following components: 2 parts of aconite root, 2 parts of tuckahoe, 1 part of cinnamon bark, 0.7 parts of frankincense, 0.7 parts of myrrh, 1.3 parts of cyathula, 1.3 parts of dragon's blood, 1.3 parts of terminalia chebula, 1 part of cuttlebone, and 1 part of zedoaria;
[0065] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0066] Step S1, weighing an appropriate amount of pharmaceutical raw materials; In step S1, drying an appropriate amount of pharmaceutical raw materials;
[0067] Step S2, grinding the medicinal raw materials into powder and mixing them; in step S2, grinding the raw materials dried in step S1 into powder; in step S2, fully sieving the ground medicinal raw materials to obtain drug powder and mixing them; in step S2, the sieving size is: 75 mm to 150 mm;
[0068] Step S3, all the mixed drug powders are made into drug micro powders; In step S3, all the mixed drug powders in step S2 are made into drug micro powders by micronization technology;
[0069] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0070] Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
[0071] Embodiment five:
[0072] Reference Figure 1 , a Chinese medicine ointment for treating urinary incontinence, characterized by comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials; the auxiliary material is honey;
[0073] The pharmaceutical raw materials include the following components: 2 parts of aconite root, 2.5 parts of tuckahoe, 1 part of cinnamon bark, 0.7 parts of frankincense, 0.7 parts of myrrh, 1.3 parts of cyathula, 1.3 parts of dragon's blood, 1.3 parts of terminalia chebula, 1 part of cuttlebone, and 1 part of zedoaria;
[0074] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0075] Step S1, weighing an appropriate amount of pharmaceutical raw materials; In step S1, drying an appropriate amount of pharmaceutical raw materials;
[0076] Step S2, grinding the medicinal raw materials into powder and mixing them; in step S2, grinding the raw materials dried in step S1 into powder; in step S2, fully sieving the ground medicinal raw materials to obtain drug powder and mixing them; in step S2, the sieving size is: 75 mm to 150 mm;
[0077] Step S3, all the mixed drug powders are made into drug micro powders; In step S3, all the mixed drug powders in step S2 are made into drug micro powders by micronization technology;
[0078] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0079] Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
[0080] Comparative Example 1:
[0081] Reference Figure 1 , a Chinese medicine ointment for treating urinary incontinence, characterized by comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials; the auxiliary material is honey;
[0082] The pharmaceutical raw materials include the following components: 1 part of aconite root, 1 part of tuckahoe, 1 part of cinnamon bark, 1 part of frankincense, 1 part of myrrh, 1 part of cyathula, 1 part of dragon's blood, 1 part of terminalia chebula, 1 part of sea cucumber, and 1 part of zedoaria;
[0083] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0084] Step S1, weighing an appropriate amount of pharmaceutical raw materials; In step S1, drying an appropriate amount of pharmaceutical raw materials;
[0085] Step S2, grinding the medicinal raw materials into powder and mixing them; in step S2, grinding the raw materials dried in step S1 into powder; in step S2, fully sieving the ground medicinal raw materials to obtain drug powder and mixing them; in step S2, the sieving size is: 75 mm to 150 mm;
[0086] Step S3, all the mixed drug powders are made into drug micro powders; In step S3, all the mixed drug powders in step S2 are made into drug micro powders by micronization technology;
[0087] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0088] Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
[0089] Comparative Example 2:
[0090] Embodiment 1:
[0091] Reference Figure 1 , a Chinese medicine ointment for treating urinary incontinence, characterized by comprising aconite root, tuckahoe, cinnamon bark, frankincense, myrrh, cyathula officinalis, dragon's blood, terminalia chebula, cuttlebone, zedoaria and auxiliary materials; the auxiliary material is honey;
[0092] The pharmaceutical raw materials include the following components: 2 parts of aconite root, 2 parts of tuckahoe, 2 parts of cinnamon bark, 2 parts of frankincense, 2 parts of myrrh, 2 parts of cyathula, 2 parts of dragon's blood, 2 parts of terminalia chebula, 2 parts of sea cucumber, and 2 parts of zedoaria;
[0093] A Chinese medicine ointment for treating urinary incontinence comprises the following steps:
[0094] Step S1, weighing an appropriate amount of pharmaceutical raw materials; In step S1, drying an appropriate amount of pharmaceutical raw materials;
[0095] Step S2, grinding the medicinal raw materials into powder and mixing them; in step S2, grinding the raw materials dried in step S1 into powder; in step S2, fully sieving the ground medicinal raw materials to obtain drug powder and mixing them; in step S2, the sieving size is: 75 mm to 150 mm;
[0096] Step S3, all the mixed drug powders are made into drug micro powders; In step S3, all the mixed drug powders in step S2 are made into drug micro powders by micronization technology;
[0097] Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice;
[0098] Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
[0099] From the above content, the ointments prepared in Examples 1 to 5 were respectively used on 100 patients, wherein the ratio of males to females in one group of patients was 50% and the ratio of males to females in another group was 50%. The specific treatment effects were as follows:
[0100]
[0101] From the above content, it can be seen that when the content of Poria cocos changes, the efficacy of the ointment is also changing. At the same time, it is more important to note that when the content of Poria cocos is 1.5, the efficacy of the ointment can be maximized. At the same time, the overall change in the content of each raw material in Example 1 and Example 2 cannot maximize the efficacy of the ointment. Therefore, the proportion of the drugs used in Example 3 is the most effective. It can be seen that the prescription of this patent takes tonifying the kidney and consolidating the body, replenishing qi and consolidating the foundation, and harmonizing the lung, spleen and kidney functions as the main principles, which can regulate the functions of human organs, regulate nerve sensitivity, and enhance the control ability of bladder muscles, thereby improving urinary incontinence symptoms.
[0102] Finally: The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A Chinese medicinal ointment for treating urinary incontinence, characterized in that; Including aconite root, Poria cocos, cinnamon bark, frankincense, myrrh, Cyathula officinalis, Dragon's blood, Terminalia chebula, cuttlebone, Zedoaria and auxiliary materials; A Chinese medicine ointment for treating urinary incontinence comprises the following steps: Step S1, weighing an appropriate amount of pharmaceutical raw materials; Step S2, grinding the medicinal materials into powder and mixing them; Step S3, making all the mixed drug powders into drug micropowders; Step S4, putting the drug powder into a container and adding aged vinegar to soak and mix well to form a Chinese medicine juice; Step S5, adding honey into the medicinal juice and mixing evenly to prepare a Chinese medicine ointment.
2. A Chinese medicinal ointment for treating urinary incontinence according to claim 1, characterized in that: The auxiliary ingredient is honey.
3. A Chinese medicinal ointment for treating urinary incontinence according to claim 1, characterized in that: The pharmaceutical raw materials include the following components: 2 parts of aconite root, 1.5 parts of poria cocos, 1 part of cinnamon bark, 0.7 parts of frankincense, 0.7 parts of myrrh, 1.3 parts of cyathula officinalis, 1.3 parts of dragon's blood, 1.3 parts of terminalia chebula, 1 part of cuttlebone, and 1 part of zelan.
4. A Chinese medicinal ointment for treating urinary incontinence according to claim 1, characterized in that: In step S1, an appropriate amount of pharmaceutical raw materials is dried.
5. The Chinese medicinal ointment for treating urinary incontinence according to claim 1, characterized in that: In step S2, the raw material dried in step S1 is ground into powder.
6. A Chinese medicinal ointment for treating urinary incontinence according to claim 1, characterized in that: In step S2, the ground medicinal raw materials are fully sieved to obtain drug powders and then mixed.
7. A Chinese medicinal ointment for treating urinary incontinence according to claim 6, characterized in that: In step S2, the screening size is 75 mm to 150 mm.
8. The Chinese medicinal ointment for treating urinary incontinence according to claim 1, characterized in that: In step S3, the drug powder mixed in step S2 is made into drug micro powder by micronization technology.